Group One Trading’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,300
Closed -$4K 5330
2016
Q4
$4K Buy
+3,300
New +$6.09K ﹤0.01% 4177
2016
Q1
Sell
-1,329
Closed -$4K 5322
2015
Q4
$4K Sell
1,329
-4,671
-78% -$19.2K ﹤0.01% 4443
2015
Q3
$25K Sell
6,000
-3,914
-39% -$25.9K ﹤0.01% 3941
2015
Q2
$94K Buy
9,914
+6,850
+224% +$96.2K ﹤0.01% 3140
2015
Q1
$51K Sell
3,064
-886
-22% -$17.4K ﹤0.01% 3357
2014
Q4
$64K Sell
3,950
-250
-6% -$5.5K ﹤0.01% 3202
2014
Q3
$108K Sell
4,200
-2,729
-39% -$65.9K ﹤0.01% 2913
2014
Q2
$173K Buy
6,929
+4,400
+174% +$112K ﹤0.01% 2558
2014
Q1
$76K Buy
2,529
+1,350
+115% +$45.4K ﹤0.01% 3309
2013
Q4
$37K Buy
1,179
+429
+57% +$13.4K ﹤0.01% 3853
2013
Q3
$21K Sell
750
-743
-50% -$18K ﹤0.01% 4160
2013
Q2
$32K Buy
+1,493
New +$36.8K ﹤0.01% 3798

Other funds holding WINT

Group One Trading's WINT Position: Q1 2017 in Review

Group One Trading sold out of Windtree Therapeutics Inc (WINT) in Q1 2017, closing a stake of 3,086 shares — an estimated $4.01K sold.

Group One Trading first reported a position in WINT in Q2 2013 and held it in 15 quarters. The position peaked at $246K in Q1 2014. 26 funds tracked by Wall St. Rank hold WINT as of Q1 2017.

  • Group One Trading reported no remaining Windtree Therapeutics Inc position as of Q1 2017 after selling out during the quarter.
  • Group One Trading sold 3,086 Windtree Therapeutics Inc shares in Q1 2017, an estimated $4.01K.
  • Group One Trading first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 15 quarters.
  • Group One Trading's Windtree Therapeutics Inc position peaked at $246K in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2017.

Based on Group One Trading's 13F filing for Q1 2017, filed 10 May 2017.